4//SEC Filing
Hrustanovic Gorjan 4
Accession 0000899243-22-022797
CIK 0001815442other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:06 PM ET
Size
5.9 KB
Accession
0000899243-22-022797
Insider Transaction Report
Form 4
Hrustanovic Gorjan
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+12,000→ 12,000 totalExercise: $14.18Exp: 2032-06-14→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2023 and (ii) the date of the next annual meeting of the Issuer's stockholders.
- [F2]The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821194
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:06 PM ET
- Size
- 5.9 KB